BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Sumitomo Corporation 

Harumi Island Triton Square Office Tower Y
8-11 Harumi 1-chome
Chuo-ku  Tokyo  104-8610  Japan
Phone: 81-3-5166-5000 Fax:


SEARCH JOBS


Industry
Suppliers


Collaborations

Dupont Pharmaceuticals Research Laboratories  Target implicated in osteoarthritis and rheumatoid arthritis





 Company News
Sumitomo Corporation Proton Therapy System Clears FDA 510(k) 12/1/2013 10:01:04 PM    More...
Oxford Finance Expands Capital Base with $460 Million Commitment From Sumitomo Corporation of America and Welsh, Carson, Anderson & Stowe 4/26/2011 10:07:43 AM    More...
Sumitomo Corporation Named Exclusive Distribution and Sales Agent for Chiral Quest, Inc. 4/15/2008 8:14:59 AM    More...
UCB Japan Co., Ltd. Announces Sales Channel Change Of Zyrtec Tablet In Japan 10/19/2005 5:13:08 PM    More...
DNA Chip Research, Sumitomo Bakelite Co-develop Innovative DNA Microarray 10/19/2005 5:12:34 PM    More...
Sumitomo Pharmaceuticals Co. Ltd. To Transfer Its Antitumor Antibiotic Sales To Nippon Kayaku Co., Ltd. 10/19/2005 5:12:24 PM    More...
Dainippon Pharmaceutical Buying Sumitomo In $2.2 Billion Stock Deal 10/19/2005 5:12:18 PM    More...
BioTime (BTX) Announces Agreement To Develop Hextend And PentaLyte In Japan 10/19/2005 5:10:53 PM    More...
Olympus Biomaterial Corp. To Take Over Sumitomo Pharmaceuticals Co. Ltd.'s Bone Replacement Material Business 10/19/2005 5:10:20 PM    More...
Dainippon Pharmaceutical And Sumitomo Pharmaceuticals Co. Ltd. Announce Details Of Upcoming Merger 10/19/2005 5:09:54 PM    More...
12

//-->